Metabolic Acidosis May Be an Important Contributing Cause of Age-Related Frailty

Key Takeaways

• Low serum bicarbonate (<25 mEq/L) predicts slower gait speed.
• Mild metabolic acidosis linked to sarcopenia via catabolic signaling.
• Risk persists even with normal kidney function (GFR >60).
• Human studies lack longitudinal data to confirm causality.

Pulse Analysis

Metabolic acidosis, often measured by serum bicarbonate, is emerging as a subtle yet measurable factor in the frailty cascade that affects older adults. While clinicians traditionally focus on kidney disease or overt electrolyte disturbances, recent epidemiologic work shows that even modest drops in bicarbonate—still within the low‑normal range—correlate with diminished physical performance, slower gait, and heightened mortality risk. This relationship holds true for seniors whose glomerular filtration rate remains above 60 mL/min/1.73 m², suggesting that the acid‑base imbalance itself, rather than renal decline, may be a key player.

The biological mechanisms linking acidosis to frailty are rooted in muscle metabolism. Acidic environments stimulate catabolic pathways, impair insulin signaling, and elevate inflammatory cytokines, all of which converge on mitochondrial dysfunction and oxidative stress. These changes mirror the cellular hallmarks of sarcopenia, the age‑related loss of muscle mass and strength. In chronic kidney disease, where acidosis is more pronounced, similar pathways accelerate muscle wasting, reinforcing the plausibility that milder acidosis could have comparable effects in the broader aging population.

Despite compelling mechanistic data, the field lacks robust longitudinal studies tracking pH balance alongside frailty onset in humans. Without such evidence, it remains unclear whether low bicarbonate is a driver, a biomarker, or a downstream consequence of muscle degeneration. Establishing causality could open inexpensive therapeutic avenues—dietary alkali supplementation, targeted exercise, or pharmacologic buffering—to mitigate frailty and improve quality of life for the growing elderly demographic.